Tucker Asset Management LLC Ocugen, Inc. Transaction History

Tucker Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.82 - $1.33 $245 - $399	-300 Closed	0 $0
Q4 2022 May 11, 2023	SELL	$1.11 - $1.87 $333 - $561	-300 Closed	0 $0
Q2 2022 May 11, 2023	BUY	$1.83 - $3.45 $549 - $1,035	300 New	300 $681,000
Q1 2022 May 11, 2023	BUY	$2.34 - $4.72 $702 - $1,416	300 New	300 $990,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tucker Asset Management LLC with notifications on news.